Ontology highlight
ABSTRACT:
SUBMITTER: Peraldo-Neia C
PROVIDER: S-EPMC5774843 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Peraldo-Neia Caterina C Cavalloni Giuliana G Fenocchio Elisabetta E Cagnazzo Celeste C Gammaitoni Loretta L Cereda Stefano S Nasti Guglielmo G Satolli Maria Antonietta MA Aprile Giuseppe G Reni Michele M Avallone Antonio A Spadi Rosella R Venesio Tiziana T Martin Vittoria V Doglioni Claudio C Frattini Milo M Aglietta Massimo M Leone Francesco F
PloS one 20180119 1
The association of anti-EGFR to gemcitabine and oxaliplatin (GEMOX) chemotherapy did not improve survival in biliary tract carcinoma (BTC) patients. Multiple mechanisms might be involved in the resistance to anti-EGFR. Here, we explored the mutation profile of EGFR extracellular domain (ECD), of tyrosine kinase domain (TKD), and its amplification status. EGFR mutational status of exons 12, 18-21 was analyzed in 57 tumors by Sanger sequencing. EGFR amplification was evaluated in 37 tumors by Fluo ...[more]